Skip to main content
. 2016 Mar 7;9:1167–1173. doi: 10.2147/OTT.S102265

Figure 3.

Figure 3

Efficacy associated with VEGFR-TKIs treatment compared with placebo treatment: (A) OS, (B) PFS, (C) ORR.

Abbreviations: CI, confidence interval; ORR, objective response rate; OS, overall survival; PFS, progression-free survival; VEGFR-TKIs, vascular endothelial growth factor receptor tyrosine kinase inhibitors.